Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Lonza Group Stock News

LZAGYOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$69.47

0.570.83%

At close: -

$67.65

-1.82-2.62%

After Hours: Apr 23, 4:00 PM EDT

Lonza Group (LZAGY) Forecast

News

Earnings Lonza Group (LZAGY) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest Lonza Group Stock News | OTC:LZAGY | Benzinga

Get the latest news on Lonza Group stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Lonza Group performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, December 12, 2024

Swiss Contract Service Provider Lonza Exits Capsules Business To Focus On Drug Development
Vandana Singh - Dec 12, 2024, 12:46PM

Wednesday, March 20, 2024

Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
Vandana Singh - Mar 20, 2024, 12:38PM

Wednesday, June 22, 2022

Galapagos Bets €225M On CellPoint Marking Its Entry Into CAR-T Field
Vandana Singh - Jun 22, 2022, 6:39AM

Wednesday, June 02, 2021

Moderna, Lonza Team Up To Produce New Drug Substance for COVID-19 Vaccine Doses
Vandana Singh - Jun 2, 2021, 6:54AM

Thursday, April 29, 2021

Moderna Tries To Boost COVID-19 Vaccine Supply Chain To Produce 3B Doses Annually
Vandana Singh - Apr 29, 2021, 8:26AM

Wednesday, April 14, 2021

aTyr Pharma Recruits Lonza As Manufacturing Partner For Cancer Therapy ATYR2810
Vandana Singh - Apr 14, 2021, 9:42AM

Friday, March 12, 2021

Altimmune Shares Are Trading Higher On Expanded Manufacturing Pact With Lonza
Vandana Singh - Mar 12, 2021, 6:10AM

Tuesday, February 23, 2021

Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2021
Benzinga Insights - Feb 23, 2021, 11:07AM
JP Morgan Upgrades Lonza Group to Overweight
Benzinga Newsdesk - Feb 23, 2021, 8:26AM

Tuesday, November 10, 2020

KeyBanc Initiates Coverage On Lonza Group wit...
Benzinga Newsdesk - Nov 10, 2020, 4:14AM

Monday, July 27, 2020

Moderna Gets Another $472M Federal Funding For Late-Stage Coronavirus Vaccine Development
Shivdeep Dhaliwal - Jul 26, 2020, 10:38PM

Tuesday, March 24, 2020

Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights - Mar 24, 2020, 11:35AM

Thursday, February 13, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin - Feb 13, 2020, 10:26AM

Wednesday, February 12, 2020

Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin - Feb 12, 2020, 11:45AM

Tuesday, February 11, 2020

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin - Feb 11, 2020, 10:17AM

Wednesday, January 22, 2020

Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin - Jan 22, 2020, 10:17AM

Tuesday, January 21, 2020

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin - Jan 21, 2020, 10:11AM

Thursday, January 16, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin - Jan 16, 2020, 10:22AM

Thursday, October 17, 2019

The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO
Shanthi Rexaline - Oct 17, 2019, 7:39AM
Mesoblast, Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast's Potential First United States Allogeneic Cell Therapy
Charles Gross - Oct 17, 2019, 4:08AM

Tuesday, October 08, 2019

The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration
Shanthi Rexaline - Oct 8, 2019, 7:11AM
Prevail Therapeutics and Lonza Establish Strategic Collaboration to Develop and Manufacture Prevail's Novel AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases
Charles Gross - Oct 8, 2019, 4:25AM

Friday, August 09, 2019

A List Of Stocks Reaching New 52-Week Highs
Lisa Levin - Aug 9, 2019, 10:29AM

Thursday, August 08, 2019

Stocks That Set New 52-Week Highs Thursday
Lisa Levin - Aug 8, 2019, 12:19PM

Tuesday, July 23, 2019

Stocks that Broke 52-Week Highs Tuesday
Lisa Levin - Jul 23, 2019, 2:39PM

Wednesday, June 19, 2019

Gamida Cell,Lonza Establish Commercial Manufacturing Agreement for Omidubicel
Charles Gross - Jun 19, 2019, 4:31AM

Tuesday, July 17, 2018

Waters Has Limited Upside Potential To Growth Expectations; Janney Steps to The Sidelines
Benzinga - Jul 17, 2018, 12:55PM

Thursday, April 14, 2016

Benzinga's M&A Chatter for Wednesday April 13, 2016
Benzinga - Apr 13, 2016, 8:39PM

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved